Our results showed that the CD86 marker of the M1 phenotype, and the CD163, ARG1 and MRC1 markers of the M2 phenotype were significantly correlated with SLC2A3 expression in GC (p < 0.0001) (Fig. 5c). The gene discussed is ARG1; the disease is gastric cancer.